SEE OUR POSTER PRESENTATIONS
Saturday 28 September
Poster Presentation 1560P | Disease monitoring of EGFR mutation-positive NSCLC patients via circulating tumor DNA
Poster Presentation 1559P | An exploratory analysis of on-treatment ctDNA measurement as a potential surrogate for overall survival for atezolizumab benefit in the OAK Study
Poster Presentation 1744P | Mutational profiling of tumor tissue and sequential plasma illustrates emergent clones during treatment in late stage small cell lung cancer (SCLC)